|
The list below contains all FTC press releases related to competition in the health care industry from 1995 to the present. Many of the current press releases contain links to the supporting case documents such as complaint filings and consent orders.
2012
- For Your Information: August 7, 2012
FTC Approves Final Order Settling Charges that Johnson & Johnson's Proposed Acquisition of Synthes, Inc. was Anticompetitive in Market for Treating Traumatic Wrist Injuries
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Johnson & Johnson's proposed acquisition of Synthes, Inc. would have been anticompetitive in the market for surgical systems used to treat traumatic distal radius wrist fractures.
- For Your Information: July 3, 2012
FTC Approves Amended Final Order Settling Charges that Teva's Proposed Acquisition of Cephalon was Anticompetitive in Markets for Several Generic Drugs
Following a public comment period, the Federal Trade Commission has approved an amended final order settling charges that Teva Pharmaceutical Industries, Ltd.'s proposed acquisition of rival Cephalon, Inc. would have been anticompetitive in the markets for several current and future generic drugs.
- For Your Information: June 26, 2011
FTC Issues Modified Final Order Settling Charges that Perrigo's Acquisition of Paddock Laboratories Was Anticompetitive in Market for Generic Pharmaceuticals
Following a public comment period, the Federal Trade Commission has issued a modified final order settling charges that Perrigo Company's $540 million acquisition of Paddock Laboratories, Inc., as proposed, was anticompetitive and would have reduced the number of manufacturers for four products used to treat conditions such as skin disorders, allergic reactions, and nausea.
- For Release: June 11, 2012
FTC Puts Conditions on Johnson & Johnson's Proposed Acquisition of Synthes, Inc.
J&J Required to Sell System for Treating Distal Radius Wrist Fractures to Biomet, Inc.
2011
-
For Your Information: May 24, 2011
FTC Files Amicus Brief in U.S. Court of Appeals for the Third Circuit in K-Dur Antitrust Litigation Urging Reversal of Pay-for-Delay Ruling
The Federal Trade Commission filed an amicus brief before the U.S. Court of Appeals for the Third Circuit in support of private class action plaintiffs who have challenged the legality of patent settlements between branded and generic manufacturers of the high blood pressure medication K-Dur 20.
-
For Release: May 10, 2011
FTC Staff Finds Sanofi-Aventis, Watson Pharmaceuticals, and Synthon Holding B.V. Failed to Report Drug Patent Agreements as Required by Law
Agency Does Not Take Enforcement Action, But Urges Industry to Closely Consider Advisory
-
For Release: May 10, 2011
FTC Settlement Order Bars Texas Doctors' Group from Joint Price Negotiations
Action is Agency’s Latest Effort to Protect Consumers from Higher Health Care Costs
-
For Release: May 3, 2011
FTC Staff Report Finds 60 Percent Increase in Pharmaceutical Industry Deals That Delay Consumers' Access to Lower-Cost Generic Drugs
Deals Are Costing Taxpayers, Consumers Billions of Dollars
-
For Release: April 27, 2011
FTC Requires Hikma to Sell Two Drugs as Condition of Baxter Healthcare Acquisition
Generic Injectables Used to Control Seizures and Treat Allergies, Nausea, Pain, and Anxiety
-
For Your Information: April 22, 2011
FTC Dismisses Complaint in LabCorp
By a vote of 5-0, the Federal Trade Commission has issued an order dismissing its complaint in Laboratory Corporation of America’s acquisition of Westcliff Medical Laboratories, Inc., and closing the Commission’s investigation of the matter.
-
For Release: April 20, 2011
FTC and Georgia Attorney General Challenge Phoebe Putney Health System’s Proposed Acquisition of Palmyra Park Hospital as Anticompetitive
Health Care Rate Increases Would be Shouldered by Albany, Georgia Employers, Employees
-
For Release: April 8, 2011
FTC Bureau of Competition Director Issues Statement on Providence Health & Services’ Abandonment of its Plan to Acquire Spokane Cardiology and Heart Clinics Northwest
Richard Feinstein, Director of the Federal Trade Commission’s Bureau of Competition, issued a statement on the decision by Providence Health & Services to abandon its plans to acquire Spokane Cardiology and Heart Clinics Northwest in Spokane, Washington.
-
For Release: March 31, 2011
FTC, DOJ Seek Public Comment on Proposed Statement of Antitrust Enforcement Policy Regarding Accountable Care Organizations
Provides for Antitrust "Safety Zone" and Expedited Antitrust Review
-
For Release: February 8, 2011
FTC Denies North Carolina Dental Board's Motion to Dismiss Allegations That it Stifled Competition for Teeth-Whitening Services
Commission Finds That Board's Conduct is Not Protected by the State Action Doctrine
-
For Release: January 6, 2011
FTC and Ohio Attorney General Challenge ProMedica's Acquisition of St. Luke's Hospital
Allege Acquisition Will Increase Healthcare Costs in Lucas County, Ohio
2010
-
For Release: December 1, 2010
FTC Challenges LabCorp's Acquisition of Rival Clinical Laboratory Testing Company
Alleges Integration of Westcliff Medical Laboratories Would Lead to Higher Prices, Lower Quality
-
For Release: November 15, 2010
FTC Requires Universal Health Services to Sell 15 Psychiatric Facilities as a Condition of Acquiring Rival Psychiatric Solutions
The Federal Trade Commission will require Universal Health Services, Inc., one of the nation’s largest hospital management companies, to sell 15 psychiatric facilities as a condition of its $3.1 billion acquisition of Psychiatric Solutions, Inc.
-
For Your Information: September 8, 2010
FTC, HHS Office of Inspector General, and Centers for Medicare & Medicaid Services Announce Workshop on Issues Related to Accountable Care Organizations
Public Event to be Held at CMS Headquarters in Baltimore on October 5, 2010
-
For Your Information: August 19, 2010
FTC Staff Opinion: Yakima Valley Memorial Hospital's Proposed Rx Program Exempt From the Robinson-Patman Act
Program Falls Within the Scope of the Non-Profit Institutions Act
-
For Your Information: July 2, 2010
FTC Staff Opinion: Community CarePartners, Inc.'s Proposed Discount Rx Program Exempt From the Robinson-Patman Act
Program Falls Under Non-Profit Institutions Act
-
For Release: June 18, 2010
Minnesota Health Care Provider Group Settles FTC Price Fixing Charges
A group of doctors and hospitals in southwestern Minnesota has agreed to a settlement with the Federal Trade Commission that prohibits anticompetitive tactics the group allegedly used to increase health insurance reimbursement rates.
-
For Your Information: June 14, 2010
FTC Chairman Addresses American Medical Association
In a speech to the American Medical Association in Chicago, Federal Trade Commission Chairman Jon Leibowitz announced that the FTC will hold a public workshop this fall on health care competition policy, payment reform, and the new models for delivering health care that seek to incentivize high-quality, cost-effective care.
-
For Your Information: May 25, 2010
FTC Files Amicus Brief in Support of Rehearing of Ciprofloxacin "Pay-for-Delay" Case
The Federal Trade Commission has filed an amicus brief in the U.S. Court of Appeals for the Second Circuit, recommending that it hold a rehearing before all the judges of the Ciprofloxacin (Cipro) "pay-for-delay" case.
-
For Release: April 29, 2010
Statement by FTC Chairman Jon Leibowitz Regarding Today’s Decision by the U.S. Court of Appeals for the Second Circuit in the Ciprofloxacin "Pay-for-Delay" Case
FTC Chairman Jon Leibowitz issued the following statement regarding today’s decision by the U.S. Court of Appeals for the Second Circuit, which invited the plaintiffs in the Ciprofloxacin drug patent settlement case to seek further review by the full court of appeals because of the “exceptional importance” of the antitrust implications of pay-for-delay settlements.
-
For Your Information: April 9, 2010
FTC Staff Opinion: University of Michigan’s Proposed Rx Program Exempt From Robinson-Patman Act
School Falls Under Nonprofit Institutions Act
-
For Your Information: April 9, 2010
FTC Provides Comments to FCC on Protecting Children in Traditional and New Media Environments;
FTC Approves Final Settlement Order Regarding The M Group, Inc., Doing Business As Bamboosa;
FTC Approves Final Settlement Order Regarding Roaring Fork Valley Physicians I.P.A.;
FTC Approves Final Settlement Order with Richard Stanton
-
For Your Information: April 6, 2010
FTC Approves Final Settlement Orders Regarding Boulder Valley IPA and M. Catherine Higgins;
Commission Submits Comments on Measuring the Performance of Electric Regional Transmission Organizations and on FERC’s Method of Assessing Partial Acquisitions
-
For Your Information: March 30, 2010
Commission Approves Carilion Clinic's Application to Sell Center for Surgical Excellence to Fairlawn Surgery Center, LLC
The Federal Trade Commission has approved a proposed divestiture by Virginia-based health care company Carilion Clinic. Under a December 2009 settlement with the FTC, Carilion must divest a medical imaging center and an outpatient surgical center in Roanoke, Virginia, to FTC-approved buyers.
-
For Release: March 29, 2010
Statement by FTC Chairman Jon Leibowitz
Regarding Today’s District Court Decision Denying a Motion to Dismiss the Commission’s Pay-For-Delay Case Against Cephalon Inc.
-
For Release: March 23, 2010
FTC Approves Final Settlement Order Regarding Danaher Corporation and MDS, Inc.
Following a public comment period, the Federal Trade Commission has approved a final settlement order in the matter of Danaher Corporation and MDS, Inc., and sent a letter to the one member of the public who commented on it.
-
For Release: March 18, 2010
Statement by FTC Chairman Jon Leibowitz Regarding Continuing Need for Legislation Banning Illegal Pay-for-Delay Drug Settlements
The Federal Trade Commission will continue working on behalf of Americans who are struggling to pay for their health care.
- For Release: February 22, 2010
Statement of Federal Trade Commission Chairman Jon Leibowitz on Ending “Pay-for-Delay” Drug Settlements, Praises Inclusion in President’s Health Care Proposal
“When drug companies agree not to compete, consumers lose,” said Federal Trade Commission Chairman Jon Leibowitz.
- For Release: February 5, 2010
FTC Settles Charges That Colorado Physicians’ Group Director Attempted to Evade Terms of 2008 Price-Fixing Order
The Federal Trade Commission settled charges that the executive director of a Colorado physicians’ association actively tried to evade the terms of a 2008 FTC order.
- For Release: February 3, 2010
Colorado Physicians Group Agrees to Stop Alleged Price-Fixing Tactics
A Colorado physicians’ group has settled Federal Trade Commission charges of price-fixing by agreeing to halt its use of allegedly anticompetitive negotiating tactics against health insurers.
- For Release: February 2, 2010
Commission Approves FY 2011 Budget Request and GPRA Performance Plans for Submission to Congress; FTC Staff: Proposed Kentucky Regulations for Licensing Retail Clinics Raise Competitive Concerns; FTC Issues Annual Financial Acts Enforcement Report to Federal Reserve
The Federal Trade Commission has approved its FY 2011 Budget Overview Statement and the Government Performance and Results Act (GPRA) Performance Plans for FY 2010 and FY 2011.
- For Your Information: January 29, 2010
FTC Approves Final Consent Order in Case of Pfizer Inc. and Wyeth
Following a public comment period, the Federal Trade Commission has approved a final consent order regarding Pfizer Inc.’s recent acquisition of Wyeth, and responses to members of the public who provided comments.
For Release: January 27, 2010
FTC Order Preserves Competition in Market for Important Scientific Research Device, While Allowing Danaher to Proceed with Purchase of MDS Analytical Technologies
The Federal Trade Commission announced today that it will require the divestiture of MDS Inc.’s assets related to its laser microdissection business as a condition of allowing Danaher Corporation and MDS Analytical Technologies (US) Inc. to proceed with their proposed merger.
-
For Your Information: January 26, 2010
Commission Seeks Public Comments on Carilion Clinic’s Application to Divest Center for Surgical Excellence to Fairlawn Surgery Center, LLC; FTC Approves The Dow Chemical Company’s Petition to Divest its Acrylic Acid and Latex Polymers Businesses to Arkema Inc.; FTC Approves Amended Complaint in Matter of JPM Accelerated Services, Inc.
-
For Your Information: January 19, 2010
Commission Announces Revised Filing Thresholds for Clayton Act Antitrust Reviews;
Following Review, Commission Decides to Retain the Amplifier Rule;
FTC Approves Final Consent Orders in Cases Against Six Businesses That Claimed to Comply With an International Privacy Framework;
FTC Approves Final Consent Order in Matter Concerning Watson Pharmaceuticals and Arrow Pharmaceuticals
- For Release: January 19, 2010
Commission Announces Revised Filing Thresholds for Clayton Act Antitrust Reviews; Following Review, Commission Decides To Retain The Amplifier Rule; FTC Approves Final Consent Orders In Cases Against Six Businesses That Claimed To Comply With An International Privacy Framework; FTC Approves Final Consent Order In Matter Concerning Watson Pharmaceuticals and Arrow Pharmaceuticals
The Federal Trade Commission, by a vote of 4-0, has approved a Federal Register notice announcing the revised thresholds for the Hart-Scott-Rodino (HSR) Antitrust Improvements Act, which requires premerger notification for certain large transactions.
- For Release: January 13, 2010
FTC Chairman, Members of Congress Call for Legislation to End Sweetheart “Pay-for-Delay” Deals That Keep Generic Drugs Off the Market
Agreements Cost Consumers Billions of Dollars Each Year, Delay Market Entry of Generic Medicines by an Average of 17 Months
- For Release: January 13, 2010
Federal Trade Commission Chairman Jon Leibowitz and Key Members of Congress Renewed Their Call For Legislation
FTC Chairman, Members of Congress Call for Legislation to End Sweetheart “Pay-for-Delay” Deals That Keep Generic Drugs Off the Market. Agreements Cost Consumers Billions of Dollars Each Year, Delay Market Entry of Generic Medicines by an Average of 17 Months.
2009
-
For Release: December 23, 2009
Bureau of Competition Director Issues Statement on FTC’s Closure of its Investigation of Consummated Hospital Merger in Temple, Texas
Richard Feinstein, Director of the Federal Trade Commission’s Bureau of Competition, has issued a statement on the agency’s decision to close its investigation into a consummated hospital merger in Temple, Texas.
-
For Release: December 2, 2009
FTC Order Ensures Future Competition for Parkinson’s and Chemotherapy Drugs That Watson’s Acquisition of Arrow Would Have Eliminated
Generic Drug Makers Required to Sell Rights to Two Products to FTC-Approved Buyers
-
For Your Information: December 1, 2009
Commission Issues 2009 Report on U.S. Ethanol Market Concentration; FTC Approves Final Consent Order in Matter Concerning Carilion Clinic
-
For Release: October 29, 2009
FTC Order Restores Competition Lost Through Schering-Plough’s Acquisition of Merck
Merck & Co., Inc. must sell its interest in Merial Limited, an animal health joint venture with Sanofi-Aventis S.A., and Schering-Plough must sell its assets related to significant drugs for nausea and vomiting in humans, in order for Schering-Plough to complete its proposed $41.1 billion acquisition of Merck, the Federal Trade Commission announced today.
-
For Release: October 27, 2009
U.S. Court of Appeals Enforces Subpoenas in FTC’s Androgel Investigation; In Separate Case, FTC Files Petition to Compel Enforcement of Subpoena Issued to Boehringer Ingelheim
The Federal Trade Commission today announced two subpoena enforcement actions challenging tactics that delay agency investigations
-
For Release: October 15, 2009
Statement of FTC Chairman Jon Leibowitz
Senate Judiciary Committee’s Passage of the Preserve Access to Affordable Generics Act (S. 369)
-
For Release: October 14, 2009
FTC Order Prevents Anticompetitive Effects from Pfizer’s Acquisition of Wyeth
The Federal Trade Commission today announced a settlement resolving its extensive investigation of Pfizer Inc.’s proposed $68 billion acquisition of Wyeth and requiring significant divestitures to preserve competition in multiple U.S. markets for animal pharmaceuticals and vaccines.
-
For Release: October 7, 2009
Commission Order Restores Competition Eliminated by Carilion Clinic's Acquisition of Two Outpatient Clinics
Carilion Clinic, a Virginia-based health care company, has agreed to sell two independent outpatient medical clinics it acquired last year to settle Federal Trade Commission charges that the acquisitions were anticompetitive and violated federal law.
-
For Release: July 31, 2009
Statement by FTC Chairman Jon Leibowitz on Adoption of the Pay for Delay Amendment to the America’s Affordable Health Choices Act of 2009 by the House Energy and Commerce Committee
-
For Release: July 31, 2009
Bureau of Competition Statement Regarding the Announcement that Thoratec Corporation Will Not Proceed with Its Proposed Acquisition of HeartWare International
Following the Federal Trade Commission’s approval of a lawsuit to block the transaction, Thoratec Corporation today announced that it has abandoned its proposed $282 million acquisition of HeartWare International.
-
For Release: July 30, 2009
FTC Challenges Thoratec's Proposed Acquisition of HeartWare International
The Federal Trade Commission has authorized a lawsuit to block Thoratec Corporation’s proposed $282 million acquisition of rival medical device maker HeartWare International, Inc., charging that the transaction would substantially reduce competition in the U.S. market for left ventricular devices (LVADs), a life-sustaining treatment for patients with advanced heart failure.
-
For release: July 27, 2009
FTC Challenges Carilion’s Acquisition of Outpatient Medical Clinics
The Federal Trade Commission has issued an administrative complaint challenging Carilion Clinic’s 2008 acquisition of two outpatient clinics in the Roanoke, Virginia, area.
-
For Your Information: July 14, 2009
Commission Approves FY 2008 HSR Premerger Notification Report; FTC Approves Final Consent Order in Matter Concerning Alta Bates Medical Group
- For Release: June 24, 2009
FTC Issues Interim Report on "Authorized Generic" Drugs
The Federal Trade Commission today issued "Authorized Generics: An Interim Report," which presents the first set of results from a study conducted to examine the short-term and long-term effects of “authorized generics” on competition in the prescription drug marketplace.
- For Release: June 23, 2009
FTC Chairman Leibowitz: Eliminating “Pay-for-Delay” Pharmaceutical Settlements Would Save Consumers $3.5 Billion Annually
In a speech today before the Center for American Progress in Washington, D.C., Federal Trade Commission Chairman Jon Leibowitz said that an internal FTC analysis projects that stopping collusive “pay-for-delay” settlements between brand and generic pharmaceutical firms would save consumers $3.5 billion a year and also reap significant savings for the federal government, which pays approximately one-third of all prescription drug costs.
- For Release: July 16, 2009
FTC Testifies on Importance of Competition and Antitrust Enforcement to Lower-Cost, Higher-Quality Health Care
The Federal Trade Commission today told the Senate Subcommittee on Consumer Protection, Product Safety, and Insurance of the Committee on Commerce, Science & Transportation that competition and the agency’s antitrust enforcement improves health care in the United States in two ways – first, by preventing or stopping anticompetitive agreements to raise prices and second, by helping to spur innovation that improves care and expands consumer access.
- For Release: June 11, 2009
FTC Testifies on "Competition Issues and Follow-on Biologic Drugs"
Hearing Concerns Release of Agency Report Summarizing Public Roundtable Findings
-
For Release: June 10, 2009
FTC Releases Report on “Follow-on Biologic Drug Competition”
Providing FDA With Authority to Approve Follow-on Biologics Would be an Efficient Way to Bring Them to Market, Lowering Consumers’ Health Care Costs
-
For Release: June 10, 2009
FTC Releases Report on “Follow-on Biologic Drug Competition"
Providing FDA With Authority to Approve Follow-on Biologics Would be an Efficient Way to Bring Them to Market, Lowering Consumers’ Health Care Costs
-
For Your Information: June 9, 2009
Chairman, Commissioners Issue Statement on Endocare, Inc.’s Announcement That it has Terminated its Merger Agreement with Galil Medical Ltd.
-
For Release: June 9, 2009
Statement of the FTC’s Bureau of Competition Regarding the Announcement that CSL Will Not Proceed with its Proposed Acquisition of Talecris Biotherapeutics
Following the Federal Trade Commission’s filing of a lawsuit to block the transaction, CSL Limited announced on June 8, 2009, that it will not proceed with its proposed $3.1 billion acquisition of Talecris Biotherapeutics.
-
For release: June 4, 2009
FTC Settles Price-Fixing Charges Against San Francisco Bay Area Doctors’ Group
Alta Bates Medical Group, Inc. (Alta Bates), a 600-physician independent practice association serving the Berkeley and Oakland, California, area, has agreed to settle Federal Trade Commission charges that it violated federal antitrust law by fixing prices charged to health care insurers.
-
For Release: June 3, 2009
FTC Testifies in Support of Bill Banning “Pay-for-Delay” Settlements Between Brand and Generic Drug Companies
Congressional Action Needed to Prevent Higher Drug Costs to Consumers and Federal, State, and Local Governments
- For Release: May 27, 2009
FTC Authorizes Suit To Stop CSL’s Proposed $3.1 Billion Acquisition of Talecris Biotherapeutics
The Federal Trade Commission has authorized a lawsuit to block CSL Limited’s proposed $3.1 billion acquisition of Talecris Biotherapeutics Holdings Corporation, charging that the deal would be illegal and would substantially reduce competition in the U.S. markets for four plasma-derivative protein therapies – Immune globulin (Ig), Albumin, Rho-D, and Alpha-1.
- For Your Information: May 22, 2009
FTC Staff Advises Louisiana Legislature That Amended Bill Would Further Restrict Competition to Provide Dental Care to State’s Most Vulnerable Children
FTC staff have filed a comment stating that the amended version of proposed Louisiana House Bill 687, if enacted, would further restrict competition to provide dental care to underserved children in the state, without providing any countervailing benefits to consumers.
-
For Your Information: May 4, 2009
FTC Staff Advises Louisiana Legislature That Bill Would Restrict Competition to Provide Dental Care to the State’s Underserved Children;At FTC’s Request, District Court Halts Illegal Operations of Federal Loan Modification Law Center
- For Release: April 14, 2009
FTC Staff Advises Maryland Physician-Hospital Organization That it Will Not Recommend Antitrust Challenge to Proposal to Provide Member Physicians’ Services Through “Clinical Integration” Program
The Federal Trade Commission’s Bureau of Competition has advised TriState Health Partners, Inc. (TriState), a physician-hospital organization based in Hagerstown, Maryland, that staff has no present intention to recommend that the Commission challenge the organization’s proposed clinical integration program, which would include joint contracting by its members with health plans and self-insured employers.
- For Your Information: April 3, 2009
FTC Staff Comment Says New York Bill to Regulate Pharmacy Benefit Managers May Increase Pharmaceutical Prices for New York Consumers; Commission Approves Final Consent Order in Matter of Dow Chemical Company and Rohm & Haas Company
Federal Trade Commission staff filed a comment stating that provisions of New York State Senate Bill 58 would likely have the unintended consequence of increasing prices that New York consumers and health plans pay for prescription drugs. The Commission has approved a final consent order in the matter of Dow Chemical Company and Rohm & Haas Company.
- For Release: March 31, 2009
Bristol-Myers Squibb to Pay $2.1 Million Penalty for Failure to Disclose Agreement Involving Substantial Payments to Delay Entry of a Generic Version of the Drug Plavix
Drug maker Bristol-Myers Squibb Company (BMS) will pay $2.1 million – the largest fine allowed by law – for failing to inform the Federal Trade Commission of agreements reached with Apotex, Inc., regarding potential generic competition to its blockbuster drug Plavix.
- For Release: March 31, 2009
FTC Testifies in Support of Bill Banning “Pay-for-Delay” Settlements Between Brand and Generic Drug Companies
Congressional Action Necessary to Prevent Higher Pharmaceutical Costs to Consumers and Federal, State, and Local Governments
- For Your Information: March 20, 2009
FTC Staff Comment Says Bills to Authorize Collective Bargaining by Minnesota Health Care Cooperatives will Raise Health Care Costs for Minnesota Consumers
According to the staff of the Federal Trade Commission, legislation pending before the Minnesota legislature that seeks to exempt certain activities by Minnesota health care cooperatives from federal and state antitrust law likely would raise health care costs and reduce insurance coverage for Minnesota consumers.
- For Your Information: February 3, 2009
Commission Approves Final Consent Order in Matter of AllCare IPA; FTC Approves Final Consent Order in Matter of King Pharmaceuticals/Alpharma Inc.
Following a public comment period, the Commission has approved a final consent order in the matter of AllCare IPA and in the matter of King Pharmaceuticals/Alpharma Inc.
- For Release: February 2, 2009
FTC Sues Drug Companies for Unlawfully Conspiring to Delay the Sale of Generic AndroGel Until 2015
The Federal Trade Commission has filed a complaint in federal district court challenging agreements in which Solvay Pharmaceuticals, Inc. paid generic drug makers Watson Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. to delay generic competition to Solvay’s branded testosterone-replacement drug AndroGel, a prescription pharmaceutical with annual sales of more than $400 million.
- For Release: January 29, 2009
FTC Intervenes in Getinge AB’s Acquisition of Datascope Corporation
Consent Order Requires Datascope to Divest Endoscopic Vessel Harvesting Assets
2008
- For Release: December 29, 2008
FTC Intervenes in King Pharmaceuticals’ Acquisition of Rival Alpharma Inc.
King Required to Divest Painkiller Kadian to Actavis to Restore Competition
- For Release: December 24, 2008
FTC Settles Price-Fixing Charges Against Two Separate Doctors' Groups
Physicians in Modesto, California and Boulder, Colorado Required to Modify Behavior to Protect Competition
- For Release: December 19, 2008
FTC Intervenes in Teva Pharmaceutical Industries' Proposed $8.9 Billion Acquisition of Barr Pharmaceuticals
Consent Order Requires Divestitures in Twenty-Nine U.S. Generic Drug Markets
- For Release: December 16, 2008
FTC Sues Ovation Pharmaceuticals for Illegally Acquiring Drug Used to Treat Premature Babies with Life-Threatening Heart Condition
Unlawful Acquisition Resulted in Nearly 1,300 Percent Price Hike; Agency Asks Court to Require Company to Give Up Unlawful Profits
- For Release: November 18, 2008
Commission Announces Agenda for Roundtable on Follow-on Biologic Drugs
Public Roundtable to be Held in Washington, DC, on November 21, 2008
- For Your Information: October 21, 2008
Commission Approves Final Consent Order in Matter of Fresenius Medical Care AG & Co. KGaA/Daiichi Sankyo Company, Ltd.
Following a public comment period, the Commission has approved a final consent order in the matter concerning Fresenius Medical Care AG & Co. KGaA/Daiichi Sankyo Company, Ltd.
- For Your Information: September 19, 2008
FTC Extends Public Comment Period Related to Used Car Rule Review; Commission Approves Final Consent Order in Matter of Sun Pharmaceuticals and Taro Pharmaceuticals;
FTC Approves Final Consent Order in Matter of Carlyle Group Partners IV, L.P.
Commission approval of public comment period extension – The Commission has approved the publication of a Federal Register notice extending the pubic comment period related to the current regulatory review of the Used Motor Vehicle Trade Regulation Rule (Used Car Rule) through November 19, 2008.
- For Release: September 15, 2008
FTC Challenges Vertical Agreement Between Fresenius and Daiichi Sankyo
Commission Order Prevents Fresenius From Inflating Medicare Reimbursement Rates for Dialysis Drug
- For Release: August 27, 2008
FTC Announces Workshop and Roundtable on Emerging Health Care Competition and Consumer Protection Issues
Events to be Held in Washington, DC, This Fall; Public Comments Solicited
- For Release: August 13, 2008
FTC Challenges Sun Pharmaceuticals’ Purchase of Taro Pharmaceutical Industries
Consent Order Requires Sun to Sell Rights and Assets for Three Generic Drugs
- For Your Information: June 17, 2008
FTC Approves Order Dismissing Administrative Complaint Against Inova Health System Foundation and Prince William Health System, Inc.
Commission approval of order dismissing administrative complaint – The Commission has approved an order dismissing its administrative complaint against Inova Health System Foundation (Inova) and Prince William Health System, Inc. (PWHS) without prejudice, as the respondents publicly announced their mutual decision to terminate the proposed acquisition agreement.
- For Release: June 6, 2008
Statement of FTC’s Bureau of Competition regarding Inova Health System’s Announced Withdrawal of Plans to Merge with Prince William Health System
After a thorough investigation, the FTC filed a complaint in the U.S. District Court for the Eastern District of Virginia on May 12, 2008, seeking an injunction to stop the proposed combination of Inova and Prince William hospitals.
- For Your Information: June 3, 2008
FTC Approves Filing of Staff Comments Regarding Proposed Regulation of Retail Health Care Facilities in Illinois
Commission approval of filing of staff comments – The Commission has approved the filing of comments by the staff of the Office of Policy Planning and the Bureaus of Economics, Competition, and Consumer Protection with State Representative Elaine Nekritz, of the Illinois House of Representatives, regarding Illinois House Bill 5372 (HB 5372) and the proposed regulation of retail health care facilities (retail clinics) within the state.
- For Release: May 21, 2008
FTC’s Bureau of Competition Issues FY 2007 Summary of Pharmaceutical Company Settlement Agreements
Nearly Half Involved Payment to Generic Firms, Restricted Generics’ Ability to Enter the Market
- For Release: May 16, 2008
U.S. Court of Appeals Affirms FTC Decision That Texas Doctors’ Group Engaged in Illegal, Anticompetitive Price-Fixing
In a unanimous opinion issued on May 14, the U.S. Court of Appeals for the Fifth Circuit affirmed a 2005 Federal Trade Commission decision that found certain activities of North Texas Specialty Physicians (NTSP) violated Section 5 of the FTC Act.
- For Release: May 13, 2008
FTC and Virginia AG File Complaint in Federal Court Seeking to Block Inova Health System Foundation’s Acquisition of Prince William Health System
FTC and State Seek Temporary Restraining Order and Preliminary Injunction
- For Release: May 9, 2008
FTC and Virginia Attorney General Seek to Block Inova Health System Foundation’s Acquisition of Prince William Health System
Transaction Would Reduce Competition and Result in Higher Health Care Prices in Northern Virginia
- For Your Information: May 9, 2008
FTC Designates Commissioner J. Thomas Rosch as ALJ in Case Challenging Inova Health System Foundation’s Acquisition of Prince William Health System, Inc.
The Federal Trade Commission has designated Commissioner J. Thomas Rosch as the Administrative Law Judge (ALJ) in the administrative trial on the merits challenging the proposed acquisition by Inova Health System Foundation of Prince William Health System, Inc.
- For Release: April 28, 2008
FTC Issues Final Opinion and Order to Restore the Competition Lost in Evanston Northwestern Healthcare Corporation’s Acquisition of Highland Park Hospital
The Federal Trade Commission today issued its final opinion and order to restore the competition that was lost when Evanston Northwestern Healthcare Corporation (ENH) in suburban Chicago, Illinois, acquired its competitor, Highland Park Hospital.
- For Release: April 17, 2008
FTC Submits Testimony to Florida State Senate Regarding Bill That Would Amend State’s Certificate of Need Laws
At the request of Florida Governor Charlie Crist, the Federal Trade Commission has submitted written testimony on health care competition, Florida’s certificate of need (CON) laws, and Florida Senate Bill 2326 (S.B. 2326) to the Florida Governor and State Senate.
- For Your Information: April 15, 2008
Commission Approves Final Consent Order in Matter of Connecticut Chiropractic AssociationCommission approval of final consent order - Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning the Connecticut Chiropractic Association (CCA), the Connecticut Chiropractic Council (CCC), and Robert L. Hirtle (CCA’s legal counsel).
- For Release: March 17, 2008
Federal Trade Commission to Host Workshop on Health Care Clinical Integration
One-Day Public Event Scheduled for May 29, 2008, in Washington, DC
- For Release: March 10, 2008
FTC to Host Workshop on Innovations in Health Care Delivery
The Federal Trade Commission will host a workshop on April 24, 2008, to examine recent trends related to health care delivery.
- For Release: March 5, 2008
FTC Challenges Illegal Boycott of Health Plan by Connecticut Chiropractors
Chiropractors Must Modify Behavior to Protect Competition
- For Your Information: February 19, 2008
FTC Submits Testimony to Alaska House of Representatives Regarding Bill That Would Amend State’s Certificate of Need Laws
At the request of Governor Sarah Palin and the Alaska Department of Health and Social Services, the Federal Trade Commission has submitted written testimony to the Standing Committee on Health, Education, and Social Services of the state’s House of Representatives concerning health care competition, Alaska’s certificate of need (CON) laws, and House Bill 337 (H.B. 337), which would modify or repeal certain aspects of the state’s CON requirements.
- For Your Information: February 15, 2008
FTC Staff Submits Comments on Establishing Collective Bargaining for Independent Home Care Providers in Ohio
Commission approval of staff comments: At his request, staff of the FTC’s Office of Policy Planning, Bureau of Competition, and Bureau of Economics have submitted comments to Ohio State Senator William J. Seitz regarding Ohio Executive Order 2007 – 23S, issued by Governor Ted Strickland in July 2007 and entitled “Establishing Collective Bargaining for Home Health Care Workers.”
- For Your Information: February 14, 2008
FTC Staff Issues Advisory Opinion to Kaiser Foundation Health Plan, Inc., Concerning Non-Profit Institutions Act
Staff advisory opinion concerning Non-Profit Institutions Act: The staff of the Bureau of Competition has advised Kaiser Foundation Health Plan, Inc. that, in the staff’s opinion, Kaiser’s purchase and use of discounted pharmaceuticals in connection with a proposed program to provide health care services to persons covered under health benefits plans offered by self-insured employers falls within the Non-Profit Institutions Act (NPIA) exemption to the Robinson-Patman Act.
- For Release: February 13, 2008
FTC Sues Cephalon, Inc. for Unlawfully Blocking Sale of Lower-Cost Generic Versions of Branded Drug Until 2012
Complaint Charges Company Paid Four Generic Drug Makers in Order to Protect Monopoly Profits on its Leading Product
- For Your Information: February 1, 2008
Commission Staff Files Comments with Puerto Rico’s Treasury and Financial Affairs Commission on Health Care Collective Bargaining Bill
Commission approval of staff comments: The FTC’s Office of Policy Planning, Bureau of Competition, and Bureau of Economics have submitted comments to Antonio Silva Delgado of the Treasury and Financial Affairs Commission of the Puerto Rico House of Representatives regarding Senate Bill (S.B.) 2190, which would permit collective bargaining on fees and other matters for diverse individuals and corporate health care providers in Puerto Rico.
2007
- For Release: December 10, 2007
FTC Focuses Law Enforcement Lens on Unlawful Contact Lens Sales
Two marketers of non-corrective, cosmetic contact lenses have agreed to settle Federal Trade Commission charges that they violated federal law by selling lenses without prescriptions.
- For Release: November 16, 2007
FTC Challenges Schering-Plough’s Acquisition of Organon BioSciences
N.V.Companies Required to Sell Rights and Assets Related to Three Poultry Vaccines to Wyeth
- For Your Information: November 6, 2007
Commission Receives Petition to Reopen and Modify Order in Matter of Nine West Group; FTC Approves Final Consent Order in Matter of Merck KGaA and Mylan Laboratories
Petition to reopen and modify order: The Commission has received a petition from Nine West Group, Inc. to reopen and modify a prior FTC order.; Commission approval of final consent order: Following a public comment period, the Commission has approved a final consent order in the matter concerning Merck KGaA and Mylan Laboratories, Inc.
- For Your Information: October 23, 2007
FTC Approves Filing of Amended Complaint in Matter of Direct Marketing Concepts, Inc., et al.; Commission Approves Final Consent Order in Matter of Fresenius AG and American Renal Associates
Commission approval of amended complaint filing: The Commission has approved the filing of an amended complaint in the matter currently pending against Direct Marketing Concepts, Inc., et al. Commission approval of final consent order: Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning Fresenius AG and American Renal Associates.
- For Release: October 18, 2007
FTC Testifies on Community Pharmacy Fairness Act of 2007
Giving Health Care Providers License to Engage in Price Fixing and Boycotts Would be ‘Costly Step Backward on the Path to a Better Health Care System’
- For Release: October 09, 2007
FTC Challenges Kyphon’s Acquisition of Disc-O-Tech
Companies Must Divest Disc-O-Tech’s Confidence Product Line
- For Your Information: October 2, 2007
FTC Approves Filing of Staff Comments with Massachusetts Department of Public Health
Commission approval of filing of staff comments: The Commission has approved the filing of comments by the staff of the Office of Policy Planning and the Bureaus of Economics, Competition, and Consumer Protection with the Massachusetts Department of Public Health (DPH) regarding proposed limited service clinic (LSC) regulations.
- For Release: September 27, 2007
FTC Challenges Mylan’s Proposed Acquisition of Merck’s Generic Subsidiary
Companies Required to Sell Assets Related to Five Generic Pharmaceuticals
- For Your Information: September 21, 2007
FTC Staff Advises Rochester Physician Organization That It Will Not Recommend Antitrust Challenge to Proposal to Provide Member Physicians' Services Through "Clinical Integration" Program
Program Would Involve Joint Negotiation of Contracts and Prices With Health Plans
- For Your Information: September 11, 2007
Commission Approves Final Consent Orders in Matters of South Carolina State Board of Dentistry and Colegio de Optometras de Puerto Rico
Commission approval of final consent orders: The Commission has approved a final consent order in the matter concerning the South Carolina State Board of Dentistry and approved letters to the commenters of record. The Commission has approved a final consent order in the matter of Colegio de Optometras de Puerto Rico.
- For Release: September 7, 2007
FTC Challenges Illegal Agreement to Close, Acquire Dialysis Clinics
Parties Prohibited from Entry Into Similar Agreements and Required to Provide Prior Notice of Future Acquisitions in Warwick and Cranston, Rhode Island
- For Release: August 6, 2007
Commission Rules that Evanston Northwestern Healthcare Corp.’s Acquisition of Highland Park Hospital Was Anticompetitive
Unanimous Order Requires ENH to Establish Two Separate and Independent Managed Care Organization Contract Negotiating Teams
- For Release: July 30, 2007
FTC Charges Puerto Rico Optometrists’ Group, Two of its Leaders, With Orchestrating Price-Fixing Conspiracy
Consent Order Bars Group’s Doctors from Jointly Negotiating Prices or Terms of Service
- For Release: June 20, 2007
South Carolina Board of Dentistry Settles Charges That it Restrained Competition
in the Provision of Preventive Care by Dental Hygienists
FTC Complaint Alleged Conduct Limited Needy Children’s Access to Care
- For Release: June 4, 2007
FTC Challenges Rite Aid’s Proposed $3.5 Billion Acquisition of
Brooks and Eckerd Pharmacies from Canada’s Jean Coutu Group, Inc.
Consent Order Requires Sale of Stores in 23 U.S. Markets to Protect Competition
- For Your information: May 22, 2007
FTC Approves Final Consent Order in Matter of Actavis/Abrika
Commission approval of final consent order: Following a public comment period, the Commission has approved a final consent order in the matter of Actavis Group hf. and Abrika Pharmaceuticals, Inc.
- For Release: May 2, 2007
FTC Testifies Before U.S. Senate on Barriers to Entry of Generic Drugs
H.R. 1902 Called a “Fundamentally Sound” Approach to Eliminating Anticompetitive Pharmaceutical Exclusion Payments
- For Release: April 16, 2007
FTC Challenges Actavis Group's Proposed Acquisition of Abrika
To Restore Competition, Actavis Must Divest Rights to Generic Isradipine Capsules
- For Release: February 15, 2007
FTC Testifies on Patent Reform Recommendations
The Federal Trade Commission told a subcommittee of the House Judiciary Committee today that patent policy stimulates innovation by providing an incentive to develop and commercialize inventions, but that invalid or questionable patents can increase costs and hinder competition.
-
For Your Information: January 19, 2007
Commission Approves Final Consent Order in Matter of Johnson & Johnson/Pfizer
Following a public comment period, the Commission has approved the issuance of final consent order in the matter concerning Johnson & Johnson’s acquisition of Pfizer, Inc.’s Consumer Healthcare business.
- For Release: January 18, 2007
FTC Challenges Hospira/Mayne Pharma Deal
To Protect Competition, Companies Must Sell Assets for Five Generic Injectable Drugs
- For Release: January 17, 2007
FTC Provides Senate Testimony on Anticompetitive Patent Settlements in the U.S. Pharmaceutical Industry
FTC Study Shows Substantial Increase in Number of Settlements Involving a Payment to the Generic and a Restriction on Generic Entry
- For Release: January 17, 2007
Bureau of Competition Issues FY 2006 Summary of Pharmaceutical Company Settlement Agreements
Shows Substantial Increase in the Number of Settlements Involving a Payment to the Generic and a Restriction on Generic Entry
2006
-
For Release: December 29, 2006
FTC Charges Chicago-Area Doctor Groups With Price Fixing
Physicians Required to Modify Behavior to Protect Competition
-
For Release: December 12, 2006
FTC Challenges Terms of Johnson & Johnson’s Proposed Acquisition of Pfizer’s Consumer Healthcare Business To Protect Competition
Divestitures of OTC Zantac, Cortizone, Unisom, and Balmex Eliminate Anticompetitive Problems
- For Your Information: December 8, 2006
FTC Approves Final Consent Order in Barr/Pliva Matter
Following a public comment period, the Commission has approved the issuance of final consent order in the matter concerning Barr Pharmaceuticals, Inc.’s acquisition of PLIVA d.d.
- For Release: October 31, 2006
FTC Challenges Terms of Watson Pharmaceuticals’ Acquisition of Andrx
Companies Must Sell Overlapping Drug Lines to Gain FTC Approval
- For Release: October 24, 2006
Court Enters Final Order Settling FTC’s Charges Against Warner Chilcott
Terms Protect Consumers from Agreements Designed to Delay Generic Drug Launches
- For Release: October 23, 2006
Consumers Win as FTC Action Results in Generic Ovcon Launch
Commission Action Fosters Generic Drug Entry and Leads to Settlement of Charges Against Warner Chilcott
- For Release: October 20, 2006
FTC Challenges Barr’s Proposed Acquisition of Pliva
Required Divestitures in Generic Drug and Organ Preservation Solution Markets Protect Consumers and Competition
- For Release: October 17, 2006
FTC Charges That Thermo Electron’s Acquisition of Fisher Scientific Would Lessen Competition in U.S. Market for Centrifugal Vacuum Evaporators
Requires Thermo to Divest Fisher’s CVE Business to Maintain Competition
- For Your Information: October 6, 2006
Staff Submits Comments on Pharmacy Benefit Managers to Virginia House of Delegates; Commission Approves Issuance of Strategic Plan for Fiscal Years 2006-2011; FTC Approves Final Consent Order in Matter of New Century Health Quality Alliance, Inc.
The FTC has approved the filing of comments by the staffs of the Bureaus of Competition and Economics and the Office of Policy Planning with the Virginia House of Delegates on the subject of pharmacy benefit managers (PBMs). The Commission has approved the release of The Federal Trade Commission Strategic Plan for Fiscal Years 2006-2011, as required under the Government Performance and Results Act (GPRA) and through guidance issued by the Office of Management and Budget. Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning New Century Health Quality Alliance, Inc. and Prime Care of Northeast Kansas, L.L.C., et al.
- For Release: September 6, 2006
FTC Testifies on Competition in Group Health Care
The Federal Trade Commission today told the Senate Judiciary Committee that the agency protects health care consumers from anti-competitive conduct by enforcing antitrust laws, and that the FTC is committed to working with physicians and other providers to give them guidance to avoid antitrust pitfalls as they respond to market challenges.
- For Release: August 24, 2006
FTC Charges Physician Groups With Price Fixing
Physicians Must Modify Behavior to Protect Competition
- For Your Information: July 5, 2006
FTC Approves Final Consent Order in Matter of Fresenius and Renal Care
Following a public comment period, the FTC has approved the issuance of a final consent order in the matter concerning Fresenius AG and Renal Care Group.
- For Your Information: June 20, 2006
FTC Staff: Alpena, Michigan, Public Schools Planned Pharmaceutical Transfer Falls Within NPIA; Final Consent Order Approved in Nations Title Consumer Protection Matter
- For Your Information: May 19, 2006
Commission Approves Divestiture in Matter of DaVita/Gambro; FTC Approves Petition for Sale of Meow Mix Company to Del Monte Corporation; Final Consent Order Approved in Matter of Dynamic Health of Florida
The Commission has granted a petition from DaVita Inc. (DaVita) requesting approval of a proposed divestiture related to its recent acquisition of Gambro Healthcare (Gambro); Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning Vineet K. Chhabra (also known as Vincent K. Chhabra) and his companies, Dynamic Health of Florida, LLC, and Chhabra Group, LLC.
- For Release: April 24, 2006
Bureau of Competition Issues FY 2005 Summary of Pharmaceutical Company Settlement Agreements
- For Your Information: April 21, 2006
Commission Approves Final Consent Order in Matter of Allergan/Inamed
Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning Allergan, Inc.’s acquisition of Inamed Corporation.
- For Release: March 30, 2006
Maintaining Competition, FTC Allows Fresenius’ $3.5 Billion Deal to Buy Rival Dialysis Provider Renal Care Group
Settlement Requires the Sale of 91 Dialysis Clinics and Interest in 12 More in 66 Areas Across the United States
- For Release: March 29, 2006
FTC Proposes Study of Competitive Impacts of Authorized Generic Drugs
- For Release: March 28, 2006
Hospitals’ Plan for Collective Bargaining of Physicians’ Fees Likely Would Violate Federal Laws, FTC Staff Says
- For Release: March 8, 2006
Preserving Competition, FTC Requires Divestiture Before Allowing Allergan’s Acquisition of Inamed
Consent Order Requires Allergan to Divest Future Botox Rival Reloxin in $3.2 Billion Deal
- For Your Information: March 7, 2006
FTC Staff Files Comments on New Jersey’s Proposed Advertising Guideline 4; Commission Finalizes Teva/Ivax Consent Order
The Commission has authorized the staffs of the Bureau of Consumer Protection, Bureau of Economics, and Office of Policy Planning to file a letter with the New Jersey Supreme Court Committee on Attorney Advertising regarding Proposed Advertising Guideline 4, which would place certain restrictions on the use by lawyers or law firms of endorsements or testimonials from clients.; Following a public comment period, the Commission has approved a final order related to Teva Pharmaceutical Industries Ltd.’s recent acquisition of Ivax Corporation
- For Release: February 13, 2006
Texas Doctors' IPA Agrees to Settle Price Fixing Charges
- For Your Information: February 7, 2006
Davita Inc. Submits Petition for Approval of Proposed Divestiture; FTC Submits Budget Request and Performance Plans to Congress
The Commission has received a petition from DaVita Inc. (DaVita) requesting approval of a proposed divestiture related to its recent acquisition of Gambro Healthcare (Gambro).; The Commission has approved the following documents: 1) the FTC’s FY 2007 Budget Overview Statement; 2) the Government Performance and Results Act (GPRA) Performance Plans for FY 2006 and FY 2007; and 3) an Update of the President’s Management Agenda Exhibit; The Commission has approved the following documents: 1) the FTC’s FY 2007 Budget Overview Statement; 2) the Government Performance and Results Act (GPRA) Performance Plans for FY 2006 and FY 2007; and 3) an Update of the President’s Management Agenda Exhibit
- For Release: January 23, 2006
Preserving Competition, FTC Requires Divestitures Before Allowing Teva’s $7.4 Billion Acquisition of IVAX
Consent Order Requires Divestitures in 15 Generic Drug Markets
[Back to Top]
2005
- For Your Information: November 18, 2005
Announced Action for November 18, 2005
Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning DaVita, Inc. and Gambro AB.
- For Release: September 20, 2005
Announced Action for September 20, 2005
The Commission has approved a petition to reopen and modify a final order in the matter concerning White Sands Health Care System, L.L.C., Alamogordo Physician Cooperative, Inc., Dacite, Inc., and James R. Laurenza.
- For Your Information: August 19, 2005
Announced Action for August 19, 2005
The Commission approved an application for proposed divestiture by Cemex, S.A. de C.V. (Cemex) related to its recent acquisition of RMC Group PLC (RMC); The Commission has authorized the staff to file an amended complaint in the matter currently pending against Elite Designs, Inc. and Anthony Antonelli; The staff of the FTC’s Bureau of Competition has advised North Mississippi Health Services (NMHS) that its purchase of pharmaceuticals to be dispensed to patients treated at a non-profit clinic and at a non-profit hospice is covered by the Non-Profit Institutions Act (NPIA).
- For Your Information: July 5, 2005
Announced Action for July 5, 2005
Following a public comment period, the Commission has approved a final consent order in the matter concerning San Juan IPA, Inc.
- For Your Information: June 17, 2005
Announced Actions for June 17, 2005
The Commission has authorized the staff to file an amended complaint in the matter currently pending against Cleverlink Trading Limited, Real World Media, Brian D. Muir, Jesse Goldberg, and Caleb Wolf Wickman.; Commission approval of final consent order: Following a public comment period, the Commission approved the issuance of a final consent order in the matter concerning New Millennium Orthopedics, LLC, et al.
-
For Your Information: May 20, 2005
Announced Actions for May 20, 2005
The Commission has received a petition from the Dow Chemical Corporation (Dow) requesting approval of certain amendments to the “Ineos Agreement,” which is incorporated into the decision and order allowing the 2001 merger of Dow and Union Carbide. The Commission has approved a final consent order addressing only the claims relating to Count III of the Complaint in the matter concerning Evanston Northwestern Healthcare Corp., et al. The Commission’s Bureau of Consumer Protection has launched a new section on the FTC’s Web site devoted to Project Scofflaw, which tracks offenders that have violated prior Commission orders.
- For Release: April 22, 2005
FTC Requests Re-Hearing in Schering-Plough Case
- For Your Information: April 22, 2005
Announced Actions for April 22, 2005
The Commission has authorized the staff to file an amended complaint in the case currently pending against CHK Trading Corp., et al. (CHK). The staff of the Bureau of Competition has advised Stevens Hospital, in Edmonds, Washington, that its purchase of pharmaceuticals to be dispensed to patients treated by its clinic physicians is covered by the Non-Profit Institutions Act (NPIA). The Commission has approved the publication of a Federal Register notice concerning a new FTC publication incorporating model forms and procedures for identity theft victims, as required by the Fair and Accurate Credit Transactions Act (FACTA).
- For Your Information: April 19. 2005
Announced Actions for April 19, 2005
The Commission has approved a petition from Aventis S.A. (Aventis), the successor company to Hoechst AG and Rhone-Poulenc S.A. (RP) (the respondents), to reopen and modify a final consent order regarding the 1999 merger of the two companies. Following a public comment period, the Commission has approved the issuance of a final consent order and letter to the commenter of record in the matter concerning Preferred Health Services, Inc.
- For Your Information: April 7, 2005
Announced Action for April 7, 2005
The Commission has authorized the submission of a response to the U.S. Food and Drug Administration (FDA) regarding a citizen petition filed with the FDA by IVAX Pharmaceuticals, Inc. (IVAX) on January 5, 2005.
-
For Your Information: February 11, 2005
Announced Action for February 11, 2005
The Commission has authorized the staff to file a brief as amicus curiae in Teva Pharmaceuticals USA, Inc. v. Pfizer, Inc., Case No. 04-1186 (Fed. Cir.) in support of Teva’s petition for rehearing or rehearing en banc.
-
For Your Information: February 4 2005
Announced Action for February 4, 2005
Following a public comment period, the Commission has approved a final consent order in the matter concerning Genzyme Corporation and ILEX Oncology, Inc.
[Back to Top]
2004
- For Release: September 10, 2004
FTC Staff: California Bill May Raise Prices for Pharmaceuticals
In response to a request from California Assembly Member Greg Aghazarian, FTC staff have commented on a bill (AB 1960) that requires pharmacy benefit managers ("PBMs") to disclose certain information to purchasers and prospective purchasers of their services, as well as to prescribers and consumers.
- For Release: August 12, 2004
Generic Drug Marketers Settle FTC Charges
Complaint Charges Unlawful Agreement Not to Compete Drove Up Prices for Over-the-Counter Children’s Ibuprofen; Companies to Give-Up Illegal Profit
- For Your Information: May 25, 2004
Announced Actions for May 25, 2004
The Commission has authorized the filing of a joint amicus brief with the Department of Justice in McMahon v. Advanced Title Services Company of West Virginia, a case before the West Virginia Supreme Court of Appeals.The Commission has advised Bristol-Myers Squibb (BMS) that its proposed settlement with Teva Pharmaceuticals USA, Inc., does not raise issues under Section 5 of the Federal Trade Commission Act.
- For Your Information: May 11, 2004
Announced Action for May 11, 2004
By a vote of 5-0, the Commission has approved a final consent order and authorized the staff to send letters to the commentors of record in the matter concerning California Pacific Medical Group, Inc, d/b/a Brown & Toland Medical Group The Commission has published transcripts of the three-day joint FTC/DOJ Workshop on Merger Enforcement held in Washington, DC, on February 17-19, 2004.
- For Your Information: January 13, 2004
Announced Actions for January 13, 2004
The Commission has approved a petition from Wright Medical Technology, Inc. (Wright) to reopen and modify a 1994 consent order that arose from Wright’s cash tender offer for all shares of common stock and outstanding convertible preferred stock of Orthomet, Inc.; Tthe Commission has approved a final consent order and letter to the commenter of record in the matter concerning Memorial Hermann Health Network Providers.; The Commission has approved the publication of a Federal Register notice concerning the FTC’s regulatory review schedule.
- For Your Information: January 9, 2004
Announced Actions for January 9, 2004
Staff of the Commission’s Bureau of Competition has issued an advisory opinion at the request of Dunlap Memorial Hospital (Dunlap) in Orrville, Ohio, addressing whether Dunlap’s provision of pharmaceuticals to the Viola Startzman Free Clinic (Free Clinic) would fall within the scope of the Non-Profit Institutions Act (NPIA). Following a public comment period, the Commission has approved a modified final consent order in the matter concerning DSM N.V./Roche Holding AG and Koninklijke DSM N.V., et al.
[Back to Top]
2003
- For Your Information: December 19, 2003
Announced Action for December 19, 2003
The Commission has approved the publication of a Federal Register notice regarding the ceiling on allowable charges for certain disclosures under the Fair Credit Reporting Act (FCRA).
-
For Your Information: November 18, 2003
Announced Action for November 18, 2003
Following a public comment period, the Commission has approved a final consent order in the matter concerning Surgical Specialists of Yakima, P.L.L.C.; Cascade Surgical Partners, P.S.; and Yakima Surgical Associates, Inc., P.S.
- For Your Information: September 23, 2003
Announced Action for September 23, 2003
Issuance of staff advisory opinion: The staff of the FTC's Bureau of Competition has advised counsel for Bay Area Preferred Physicians (BAPP) that it does not presently intend to recommend law enforcement action if BAPP establishes a "messenger" arrangement to minimize the costs associated with contracting between physicians and health plans and other third-party payors.
- For Your Information: July 15, 2003
Announced Actions for July 15, 2003
Following a public comment period, the Commission has approved the issuance of two final consent orders in the matters concerning Anesthesia Service Medical Group, Inc. and Grossmont Anesthesia Medical Group, Inc.
- For Your Information: March 18, 2003
Announced Actions for March 18, 2003
Received a petition from Solvay S.A. (Solvay) to reopen and modify the Commission's hold separate order regarding Solvay's acquisition of Ausimont S.p.A.; Issuance of staff advisory opinions, in two separate letters, Arkansas Children's Hospital (ACH) in Little Rock, Arkansas, and Valley Baptist Medical Center (VBMC) in Harlingen, Texas.; Approved an application for a proposed divestiture pursuant to its consent agreement and order with Biovail Corporation (Biovail); Commission has authorized the staff to file a second amended complaint in the pending court matter regarding 1st Beneficial Credit Services, et al.; approved the issuance of a final consent order in the matter concerning Dainippon Ink and Chemicals, Inc.'s acquisition of certain assets of the Bayer Corporation.
- For Your Information: January 29, 2003
Announced Action for January 29, 2003
Filed an amicus brief in the U.S. District Court for the Eastern District of Pennsylvania regarding the pending patent litigation between SmithKline Beecham (now known as GlaxoSmithKline or GSK) and Apotex Corporation, Apotex, Inc. and Torpharm Inc. (Apotex) concerning GSK's antidepressant drug product, Paxil.
[Back to Top]
2002
- For Your Information: October 11, 2002
Announced Actions for October 11, 2002
Approved the issuance of final consent orders and responses to the commenters of record in the matters concerning Philips Electronics and Okie Corporation.; approved the issuance of a final consent order and response to the commenter of record in the matter concerning R.T. Welter and Associates, Inc.; R. Todd Welter; Consultants in Obstetrics and Gynecology, P.C.; Mid Town Obstetrics & Gynecology, P.C.; Mile High OB/GYN Associates, P.C.; The OB-GYN Associates, Professional Corporation; Rocky Mountain OB-GYN, P.C.; The Women's Health Group, P.C.; Cohen and Womack, M.D., P.C.; and Westside Women's Care, L.L.P. (collectively known as Professionals in Women's Care).
-
For Your Information: October 4, 2002
Announced Action for October 4, 2002
Commission has approved the issuance of a modified final consent order in the matter concerning Biovail Corporation and its branded drug Tiazac.
- For Your Information: September 6, 2002
Announced Action for September 6, 2002
Following a public comment period, the Commission has approved a final consent order, without modifications, and a letter to the commenter of record in the matter concerning Immunex Corporation and Amgen Inc.
- For Your Information: June 4, 2002
Announced Action for June 4, 2002
Order on filing of initial decision: Administrative Law Judge D. Michael Chappell has issued an order extending until June 26, 2002, the deadline for filing the initial decision in the matter of Schering-Plough Corporation, Upsher-Smith Laboratories, and American Home Products Corporation.
- For Your Information: January 9, 2002
Announced Actions for January 9, 2002
Issuance of Two Amicus Curiae Memorandum of Law Briefs: Bristol-Myers-Squibb and Buspirone and The Hearst Trust and First Data Bank; publication of Federal Register notice regarding the Trade Regulation Rule on Power Output Claims for Amplifiers Used at Home.
[Back to Top]
2001
-
For Your Information: April 30, 2001
Announced Actions for April 30, 2001
Final approval of consent in Alaska Healthcare Network, Inc.; approval of extension of time period in the matter of Baxter International, Inc.; release of Commission report: The Twenty-third Annual Report to Congress Regarding the Hart-Scott-Rodino (HSR) Premerger Notification Program
[Back to Top]
2000
[Back to Top]
1999
[Back to Top]
1998
[Back to Top]
1997
- For Release: October 2, 1997
Puerto Rican Physicians Agree To Settle FTC Charges that they Conspired To Fix Prices and Engaged in an Illegal Boycott Denying Healthcare to Residents of Puerto Rico
- For Your Information: September 26, 1997
Announced Action(s) for September 26,1997
- For Release: September 26, 1997
FTC Ends Administrative Challenge To Hospital Merger In Grand Rapids, Michigan
- For Your Information: September 5, 1997
Announced Actions for September 5, 1997
- For Your Information: August 28, 1997
Announced Actions for August 28, 1997
- For Your Information: August 12, 1997
New Jersey Pharmacists Association
- For Your Information: July 29, 1997
Announced Actions for July 29, 1997
- For Your Information: July 18, 1997
Announced Actions For July 18, 1997
- For Your Information: June 19, 1997
First Look, L.L.C.
- For Your Information: June 13, 1997
Announced Action(s) for June 13, 1997
- For Your Information: May 23, 1997
Announced Action(s) for May 23,1997
- For Your Information: May 14, 1997
Yellowstone Physicians, L.L.C.
- For Release: May 13, 1997
FTC Charges Mesa County, Colorado Physician Group with Acting To Raise Prices, Reduce Competition
- For Your Information: April 18, 1997
Staff Opinion--Foundation for the Accreditation of Hematopoietic Cell Therapy
- For Your Information: February 21, 1997
Announced Actions for February 21, 1997
- For Your Information: January 31, 1997
Mobile Health Resources, L.L.C.
- For Your Information: January 30, 1997
Ohio Ambulance Network, Inc.
- For Your Information: January 29, 1997
FTC Obtains Relief for Health Care Consumers in California County
- For Your Information: January 24, 1997
Announced Actions for January 24, 1997
[Back to Top]
1996
- For Your Information: December 9, 1996
FTC Staff Has Advised the Southwest Florida Oral Surgery Associates (SFOSA) Its Proposal To Form a "Cooperative" Does Not Appear To Violate the Antitrust Laws.
- For Release: November 18, 1996
FTC To Appeal District Court Decision in Butterworth/Blodgett Hospital Merger Case
- For Your Information: November 13, 1996
Announced Actions for November 13, 1996
- For Your Information: November 1, 1996
Announced Actions for November 1, 1996
- For Your Information: October 24, 1996
FTC Staff Issues Advisory Opinion that a Planned Survey of Hospital Prices in the Waco, Texas Area, Appears to Meet Guidelines Outlined in the Joint FTC/Department of Justice Statements of Antitrust Enforcement Policy in Health Care, Issued in August, 1996.
- For Release: October 23, 1996
Montana Physicians Agree to Settle FTC Charges that they Conspired To Raise Prices and Limit Choices for Consumers
- For Your Information: October 11, 1996
Announced Actions for October 11, 1996
- For Your Information: October 4, 1996
Announced Actions for October 4, 1996
- For Your Information: August 30, 1996
Announced Actions for August 30, 1996
- For Release: August 28, 1996
Federal Trade Commission, Justice Department Revise Policy Statements on Health Care Antitrust Enforcement
- For Your Information: August 16, 1996
Announced Actions for August 16, 1996
- For Your Information: August 2, 1996
Announced Actions for August 2, 1996
- For Your Information: July 26, 1996
Announced Actions for July 26, 1996
- For Release: July 19, 1996
Mayo Medical Laboratories
- For Your Information: June 14, 1996
Announced Actions for June 14, 1996
- For Your Information: June 7, 1996
Announced Actions for June 7, 1996
- For Your Information: May 17, 1996
Announced Actions for May 17, 1996
- For Your Information: April 5, 1996
American Medical Association
- For Release: March 26, 1996
California Dental Association
- For Your Information: March 12, 1996
More Announced Actions' for March 12, 1996
- For Release: February 27, 1996
FTC's Pitofsky Outlines How Antitrust Enforcement can Adapt to Rapidly Changing Health Care Arena
- For Your Information: February 23, 1996
Announced Actions for February 23, 1996
- For Your Information: February 2, 1996
Annouced Actions for February 2, 1996
- For Your Information: February 1, 1996
FTC Staff Have Advised a Group of New Orleans Urologists that Group's Plan to Establish a Urology Services Network Does Not Appear to Violate Antitrust Laws.
- For Release: January 19, 1996
FTC Says Action to Block Merger of Grand Rapids Hospital will Help Keep Prices Competitive at all Area Hospitals.
- For Your Information: January 18, 1996
FTC Has Approved the Application of Columbia/HCA Healthcare Corporation To Divest Its 84 Percent Partnership Interest in the Alaska Surgery Center in Anchorage, Alaska
- For Your Information: January 11, 1996
Columbia/HCA Healthcare Corporation of Nashville, Tennessee, Has Petitioned FTC to Modify an Agreement
- For Release: January 3, 1996
Robert F. Leibenluft Named to Head FTC Bureau of Competition, Health Care Shop.
- For Your Information: January 2, 1996
HEALTHSOUTH Corporation, and its Subsidiary, ReLife of Tennessee, Inc., Have Applied for FTC Approval
- For Your Information: January 2, 1996
Columbia/HCA Healthcare Corporation has Applied for FTC Approval
[Back to Top]
1995
- For Your Information: December 19, 1995
Staff of FTC Have Advised Southern Arizona Therapy Network, Inc. that Plan To Establish a Network Does Not Appear To Violate the Antitrust Laws
- For Release: December 1, 1995
FTC Ends Administrative Challenge of Hospital Merger in Joplin, Missouri
- For Your Information: November 30, 1995
FTC Approves Consent Agreement with Columbia/HCA Healthcare Corp.
- For Your Information: November 14, 1995
Columbia/HCA Healthcare Corporation Applies for Approval to Divest North Okaloosa Medical Center in Crestview, Florida.
- For Your Information: November 9, 1995
FTC Staff Advises Columbine Family Health Center Proposed Cost-Sharing Agreement with Other Hospital Does Not Appear To Violate Anitrust Laws.
- For Your Information: November 1, 1995
The American Dental Trade Association has petitioned FTC to Terminate1950 Consent Order...
- For Your Information: November 1, 1995
FTC Grants Petition to Reopen and Set Aside California Medical Association (CMA) Consent Order...
- For Your Information: October 27, 1995
Columbia/HCA Healthcare Corporation Applies for Approval...
- For Your Information: October 20, 1995
Charter Medical Corporation Petitions To Reopen and Modify a 1995 Consent Order
- For Your Information: October 19, 1995
Columbia/HCA Healthcare Corporation Has Applied for Approval To Divest Hospitals.
- For Your Information: October 5, 1995
Columbia/HCA Healthcare Corporation Settles Charges
- For Your Information: October 4, 1995
Local Health System, Inc., Blue Water Health Services Corp., and Mercy Health Services
- For Release: September 29, 1995
FTC Staff Has Advised the Central Texas Medical Group (CTMG) that Its Proposed Method of Operating is Unlikely To Violate Federal Antitrust Laws.
- For Release: September 29, 1995
FTC Staff Has Advised the Eastern Ohio Physicians Organization, Inc. (EOPO) that Its Proposed Method of Operating is Unlikely To Violate Federal Antitrust Laws.
- For Release: September 22, 1995
Hematology/Oncology Care Specialists of Western Pennsylvania, P.C
- For Release: September 22, 1995
Federal News Service Group, Inc.
- For Release: August 29, 1995
Columbia/HCA Healthcare Corp.
- For Release: August 21, 1995
Otolaryngology Specialty Providers of Georgia
- For Release: August 16, 1995
Physicians Group, Inc.
- For Release: July 25, 1995
California Dental Association
- For Release: July 13, 1995
Northwestern Nevada Orthopaedic Surgery Alliance
- For Release: July 11. 1995
Lee Memorial Hospital
- For Release: July 3, 1995
Local Health System, Inc.
- For Release: June 30, 1995
Columbia/HCA Healthcare Corporation
- For Release: June 21, 1995
Elmore Community Hospital
- For Release: June 16, 1995
California All Health
- For Release: June 12, 1995
California Medical Association
- For Release: June 8, 1995
Medical Association of Puerto Rico
- For Release: June 5, 1995
Erlanger Medical Center
- For Release: May 15, 1995
Columbia/HCA Healthcare Corporation (Correction)
- For Release: May 5, 1995
American Academy of Orthopaedic Surgeons
- For Release: April 26, 1995
Physicians Group, Inc.
- For Release: April 21, 1995
Columbia/HCA Healthcare Corporation
- For Release: April 21, 1995
Healthtrust, Inc.--The Hospital Company
- For Release: April 17, 1995
HEALTHSOUTH Corporation
- For Release: April 3, 1995
Oakland Physician Network
[Back to Top]
1993
|